ACT Laboratories
ACT Laboratories, Inc. is a US-based cannabis testing laboratory network providing analytical testing—potency, pesticide, terpene, residual solvent, and microbial analysis—to licensed cannabis cultivators, manufacturers, and dispensaries across six states.
- Company typePrivate
- Founded2011
- HeadquartersMorton, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ACT Laboratories does
ACT Laboratories, Inc., founded in 2011 and headquartered in Morton, United States, is a privately held cannabis testing laboratory network serving licensed cannabis operators. The company's offering is analytical laboratory testing across the core cannabis compliance panels — potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination analysis — delivered to cultivators, manufacturers, processors, and dispensaries that require third-party verification to meet state-mandated regulatory requirements. Its underlying technology is conventional analytical instrumentation deployed across a multi-state laboratory footprint rather than a software or AI-driven platform; pricing is per-test on a contract or transactional basis with no publicly disclosed schedule.
The business operates a B2B, enterprise field-sales motion, supplying testing services directly to licensed cannabis businesses through laboratory service agreements rather than through retail or self-service channels. Prior to September 2022, ACT Labs held an undisclosed number of state operations; on 2022-09-28 the company announced the acquisition of CDX Analytics, a Massachusetts-based cannabis testing laboratory, bringing the operational footprint to six U.S. states and explicitly signaling intent to enter additional markets by early 2023. The deal was subject to Massachusetts regulatory approval, underscoring the licensing-driven gating of expansion in the cannabis testing vertical.
Revenue mechanics are transaction-fee based, with each compliance test representing a unit of revenue from licensed operators who have no alternative to third-party testing in regulated markets. Headcount is reported in the 11–50 band and the company provides no public revenue, funding, or valuation disclosures. Leadership consists of CEO Cornelius Merlini and Founder/EVP Jeff Nemeth. The U.S. cannabis testing market is projected to reach $8.72 billion by 2030 at a 19.6% CAGR, positioning ACT Laboratories as a roll-up-oriented participant in a fragmented, regulated, and growing vertical.
ACT Laboratories firmographics
Firmographics- Name
- ACT Laboratories
- Legal name
- ACT Laboratories, Inc.
- Website
- https://actlaboratoriesinc.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ACT Laboratories, Inc. is a US-based cannabis testing laboratory network providing analytical testing—potency, pesticide, terpene, residual solvent, and microbial analysis—to licensed cannabis cultivators, manufacturers, and dispensaries across six states.
- Ownership category
- akta.pro rank
ACT Laboratories industry classification
Industry- Product category
- Cannabis Testing Services
- NAICS
- Testing Laboratories and Services (54138), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM)
- akta.pro secondary industries
- Proficiency Testing, Method Validation & Reference Materials (Food Labs) (AFALAAAK), Drug & Alcohol Testing Coordination (BPACALAE)
Keywords
Where ACT Laboratories is headquartered
LocationHeadquarters
- HQ city
- Morton
- HQ country
- United States
- HQ region
- North America
Markets served
ACT Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Cannabis Testing Services: ACT Laboratories generates revenue through providing cannabis testing laboratory services to licensed cannabis cultivators, manufacturers, and dispensaries. Services include safety testing, potency analysis, and regulatory compliance verification across legal cannabis markets.
Go-to-market motion1 record
Distribution channels1 record
ACT Laboratories product offering
Product offeringCore offering
ACT Laboratories provides analytical cannabis testing laboratory services to licensed cannabis operators, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing. Services are delivered from licensed laboratory facilities across six U.S. states to support state regulatory compliance and product safety verification for cannabis cultivators, manufacturers, processors, and dispensaries.
Product overview
ACT Laboratories operates as a cannabis testing laboratory network providing analytical testing services for the cannabis industry. The company's service offering centers on comprehensive cannabis testing, including potency, terpene, pesticide, and microbial analysis, conducted to ensure regulatory compliance for licensed cannabis businesses. The company expanded its geographic footprint through the acquisition of CDX Analytics, a Massachusetts-based cannabis testing laboratory, extending operations to six states.
Differentiator
Problem solved
Functional benefit
Products and services
- Cannabis Testing Services Comprehensive analytical cannabis testing services for licensed cannabis cultivators, manufacturers, processors, and dispensaries, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing delivered across six U.S. states for regulatory compliance and product safety verification.
Quantifiable outcome
- Expanded testing capacity and regulatory compliance across six states through CDX Analytics acquisition
Companies that use ACT Laboratories
Customer profileSegments1 record
Ideal customer profiles1 record
ACT Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
ACT Laboratories partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CDX AnalyticscoreACT Laboratories acquired CDX Analytics, a Massachusetts-based cannabis testing laboratory, as part of its geographic expansion strategy. The acquisition enhanced ACT's operational footprint to six states and expanded testing capacity and regulatory compliance capabilities. The deal was subject to regulatory approval in Massachusetts.
Scale indicators2 records
Recent moves4 records
Expansion highlights3 records
ACT Laboratories competitors and assessment
Company assessmentBroad incumbents
- SGS: SGS is a global testing, inspection, and certification company with agricultural and food testing capabilities — overlapping analytical methods and quality system expertise relevant to cannabis testing.
- Eurofins Scientific: Eurofins is a global testing services conglomerate with broad analytical testing capabilities including food, environmental, and pharmaceutical testing — comparable analytical methods and regulatory expertise at much larger scale.
Direct peers
- CW Analytical: CW Analytical is a California-based cannabis testing laboratory offering comparable compliance testing services to licensed cannabis operators.
- SC Labs: SC Labs is a multi-state cannabis testing laboratory offering a similar full-panel compliance testing menu to licensed operators, with overlapping geographic presence in Western US states.
- Steep Hill: Steep Hill is a multi-state cannabis testing and analytics company with overlapping service offerings (potency, terpene, contaminant testing) and licensed-operator customer base.
- MCR Labs: MCR Labs is a Massachusetts-based cannabis testing laboratory with comparable service offerings to ACT's CDX Analytics subsidiary and overlapping customer base in the Northeast.
- ACS Laboratory: ACS Laboratory is a multi-state cannabis testing lab offering full-panel compliance testing (potency, terpenes, pesticides, microbials, residual solvents) to licensed operators — directly comparable to ACT Labs.
- Anresco Laboratories: Anresco is an ISO-accredited cannabis and food testing laboratory providing potency, contaminant, and regulatory testing services — comparable analytical methods and customer base.
- CannaSafe: CannaSafe is a California-based cannabis testing laboratory offering potency, pesticide, residual solvent, and microbial testing — directly comparable service portfolio and customer base to ACT Labs.
- PSI (Pharmacology & Toxicology Services): PSI is a cannabis testing laboratory offering potency and contaminant testing to licensed operators, comparable in scope and customer segment to ACT Labs.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
ACT Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
ACT Laboratories leadership team
Management profileNumber of profiles
Profiles2 records
ACT Laboratories subsidiaries and ownership
Company hierarchySubsidiaries1 record
ACT Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ACT Laboratories M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ACT Laboratories
What does ACT Laboratories do?
ACT Laboratories provides analytical cannabis testing laboratory services to licensed cannabis operators, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing. Services are delivered from licensed laboratory facilities across six U.S. states to support state regulatory compliance and product safety verification for cannabis cultivators, manufacturers, processors, and dispensaries.
Is ACT Laboratories a public or private company?
ACT Laboratories is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ACT Laboratories founded?
ACT Laboratories was founded in 2011. It employs 11 to 50 people.
Where is ACT Laboratories based?
ACT Laboratories is headquartered in Morton, United States, in the North America region.
How does ACT Laboratories make money?
One revenue line is on record: cannabis Testing Services.
Who are ACT Laboratories's main competitors?
Broad incumbents on record are SGS and Eurofins Scientific. Direct peers are CW Analytical, SC Labs, Steep Hill, MCR Labs, ACS Laboratory, Anresco Laboratories, CannaSafe and PSI (Pharmacology & Toxicology Services).
Does ACT Laboratories have an API?
No public API is recorded for ACT Laboratories.
What industry is ACT Laboratories in?
ACT Laboratories's product category is Cannabis Testing Services. Its primary akta.pro industry code is HLAJAIAM, Laboratory Quality Systems, Accreditation & Proficiency Testing Programs, with a secondary code of AFALAAAK, Proficiency Testing, Method Validation & Reference Materials (Food Labs). Its NAICS code is 54138 and its SIC code is 8734.